Back
Exelixis Vs. ADMA Biologics Industry Stock Comparison
Buy
70
EXEL
Exelixis
Last Price:
$34.07
Seasonality Move:
2.85%
Buy
53
ADMA
ADMA Biologics
Last Price:
$16.30
Seasonality Move:
6.47%
Buy
53
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $15.90. The Score for ADMA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXEL Stock Price Chart
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $15.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.
EXEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 57.92 | Buy |
Chaikin Money Flow: | 1348295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.64 - 35.56) | Buy |
Bollinger Bands (100): | (28.97 - 36.09) | Buy |
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 39.35 | Sell |
Chaikin Money Flow: | -253381 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.91 - 16.99) | Sell |
Bollinger Bands (100): | (16.41 - 20.17) | Sell |
EXEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.66 | Buy |
20-day SMA: | 33.58 | Buy |
50-day SMA: | 34.3 | Buy |
200-day SMA: | 27.97 | Buy |
8-day EMA: | 33.81 | Buy |
20-day EMA: | 33.77 | Buy |
50-day EMA: | 33.71 | Buy |
200-day EMA: | 29.45 | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.36 | Sell |
20-day SMA: | 16.33 | Sell |
50-day SMA: | 17.47 | Sell |
200-day SMA: | 15.45 | Buy |
8-day EMA: | 16.2 | Sell |
20-day EMA: | 16.5 | Sell |
50-day EMA: | 17.22 | Sell |
200-day EMA: | 15.22 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.38 per share, and an increase next year of $0.54 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.24 per share.
Exelixis Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ADMA Biologics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |